Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Carson

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Leukemia & Lymphoma|September 6, 2013
High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysisJori May, Kenneth R Carson, Sara Butler, et al.
Journal of Medical Economics|May 7, 2016
Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims dataChakkarin Burudpakdee, Huamao Mark Lin, Weiying Wang, et al.
The American Journal of Managed Care|March 23, 2012
Economic evaluation of plerixafor for stem cell mobilizationSteven M Kymes, Iskra Pusic, Dennis L Lambert, et al.
Journal of Geriatric Oncology|November 1, 2019
Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin LymphomaTheodore S Thomas, Suhong Luo, Patrick M Reagan, et al.
British Journal of Haematology|February 19, 2016
Race-based differences in routine cytogenetic profiles of patients with multiple myelomaBrandon J Blue, Suhong Luo, Kristen M Sanfilippo, et al.
JAMA Dermatology|May 30, 2019
Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical ResponseLu Chen, Kenneth R Carson, Karl W Staser, et al.
Ebiomedicine|July 31, 2019
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphomaJared M Andrews, Jennifer A Schmidt, Kenneth R Carson, et al.
Research and Practice in Thrombosis and Haemostasis|November 2, 2020
Venous thromboembolism in multiple myeloma is associated with increased mortalityMartin W Schoen, Kenneth R Carson, Suhong Luo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2025
The Inflation Reduction Act and EtanerceptCharles L Bennett, Jason B Gibbons, Chadi Nabhan, et al.
The Lancet. Oncology|August 4, 2009
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) ProjectKenneth R Carson, Daniele Focosi, Eugene O Major, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|September 6, 2013
High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysisJori May, Kenneth R Carson, Sara Butler, et al.
Journal of Medical Economics|May 7, 2016
Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims dataChakkarin Burudpakdee, Huamao Mark Lin, Weiying Wang, et al.
The American Journal of Managed Care|March 23, 2012
Economic evaluation of plerixafor for stem cell mobilizationSteven M Kymes, Iskra Pusic, Dennis L Lambert, et al.
Journal of Geriatric Oncology|November 1, 2019
Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin LymphomaTheodore S Thomas, Suhong Luo, Patrick M Reagan, et al.
British Journal of Haematology|February 19, 2016
Race-based differences in routine cytogenetic profiles of patients with multiple myelomaBrandon J Blue, Suhong Luo, Kristen M Sanfilippo, et al.
JAMA Dermatology|May 30, 2019
Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical ResponseLu Chen, Kenneth R Carson, Karl W Staser, et al.
Ebiomedicine|July 31, 2019
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphomaJared M Andrews, Jennifer A Schmidt, Kenneth R Carson, et al.
Research and Practice in Thrombosis and Haemostasis|November 2, 2020
Venous thromboembolism in multiple myeloma is associated with increased mortalityMartin W Schoen, Kenneth R Carson, Suhong Luo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2025
The Inflation Reduction Act and EtanerceptCharles L Bennett, Jason B Gibbons, Chadi Nabhan, et al.
The Lancet. Oncology|August 4, 2009
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) ProjectKenneth R Carson, Daniele Focosi, Eugene O Major, et al.
Pageof 10